Strategy, formerly known as MicroStrategy, has successfully completed a massive capital raise, securing $2.5 billion through preferred stock issuance - five times the originally planned $500 million.

Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a provider of enterprise software solutions for high-growth verticals, today announced the successful delivery of the first phase of ...

In recent years, the gold market has entered a strong upward cycle, with both technical and fundamental factors driving prices higher. By mid-July 2025, various technical indicators have shown ...

NatWest maintains a comfortable capital position with a CET1 ratio of 13.6 percent, well above regulatory requirements. Earnings per share increased to 30.9 pence, while return on equity reached an ...

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital ...

Fresh Puma information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

NEWPORT BEACH, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- GivBux, Inc. (OTC: GBUX), a publicly traded Super App and charitable giving platform, announced today that it is actively reconciling ...

CSX Corporation has become a focal point of merger speculation as industry consolidation gains momentum in the U.S. railroad sector. The company's stock is attracting investor attention following ...

Fresh Vallourec information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) provides an update on the two fall of ground incidents at the 30% ...

SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced that it has received notice from The ...

The European Commission has granted approval for Bayer's cancer medication Nubeqa to be used in treating metastatic hormone-sensitive prostate cancer, marking a significant milestone for the ...